http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102158375-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-306 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-662 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-59 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-155 |
| filingDate | 2018-10-25^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-09-21^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-09-21^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102158375-B1 |
| titleOfInvention | Complex liquid fomulation comprising vitamin D emulsion and bisphosphonate and use for preventing or treating osteoporosis |
| abstract | The present invention relates to a complex liquid formulation composition comprising vitamin D (vitamin D) emulsion and bisphosphonate, and a liquid composition for preventing or treating osteoporosis comprising the composition as an active ingredient, and a method for preparing the same, The complex liquid formulation containing vitamin D or its derivatives emulsion and bisphosphonate according to the vitamin D or its derivatives stability is improved to ensure storage stability, and also can maintain a therapeutic concentration continuously, the difficulty of taking due to bisphosphonate and By minimizing side effects, patient compliance can be expected to improve, so it can be usefully used to prevent and treat osteoporosis. |
| priorityDate | 2018-10-25^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 108 of 108.